RBC Antigen Molecular Studies
Showing 1 - 25 of 8,679
Molecular Immunohematology in Ethiopian Sub-Populations
Suspended
- Immunohematology
-
Addis Ababa, EthiopiaAddis Ababa University
Feb 2, 2023
Prostate Cancer Trial in Tomsk (Whole body study and SPECT with [99mTc]Tc-BQ0413)
Enrolling by invitation
- Prostate Cancer
- Whole body study and SPECT with [99mTc]Tc-BQ0413
-
Tomsk, Russian FederationTomskNRMC
Oct 26, 2023
Covid19 Trial in Albuquerque (Quidel quickvue antigen test for COVID-19)
Active, not recruiting
- Covid19
- Quidel quickvue antigen test for COVID-19
-
Albuquerque, New MexicoUniversity of New Mexico
Aug 11, 2022
Sensitivity of Frequent SARS-CoV-2 Rapid Antigen Testing Regimen
Terminated
- Covid19
- CoV-SCAN rapid COVID-19 antigen test
-
New York, New YorkColumbia University Irving Medical Center
Nov 11, 2021
Iron Deficiency Trial in New York (Iron-dextran, Saline, Blood Donation)
Active, not recruiting
- Iron Deficiency
- Iron-dextran
- +3 more
-
New York, New YorkColumbia University Medical Center
Feb 14, 2022
Lung Cancer, Lung Nodule, Non Small Cell Lung Cancer Trial in Philadelphia (SGM-101, Near infrared camera imaging system)
Completed
- Lung Cancer
- +2 more
- SGM-101
- Near infrared camera imaging system
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jun 15, 2022
Prostate Cancer, Elevated Prostate Specific Antigen (PSA) Trial in Brooklyn, New York (serum specimens obtained will be utilized
Active, not recruiting
- Prostate Cancer
- Elevated Prostate Specific Antigen (PSA)
- serum specimens obtained will be utilized for proteomic profiling comprising MALDI-TOF MS, and serum biomarker assays.
-
Brooklyn, New York
- +2 more
Nov 1, 2022
Bioaerosol Sampling Device (BSD) Clinical Study
Recruiting
- COVID-19
-
S. Gate, California
- +5 more
Sep 14, 2023
Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,
Recruiting
- Breast Carcinoma
- +10 more
- Computed Tomography
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022
Hematologic Malignancy Trial in Bologna
Recruiting
- Hematologic Malignancy
-
Bologna, ItalyProgramma Dipartimentale Terapie Cellulari Avanzate
Apr 17, 2023
Triple Negative Breast Cancer Trial (Cryoablation, Cryoablation combined with PD1 Inhibitor)
Not yet recruiting
- Triple Negative Breast Cancer
- Cryoablation
- Cryoablation combined with PD1 Inhibitor
- (no location specified)
Mar 28, 2023
Using IMC to Analyze the Impact of ICANS on Microglia
Recruiting
- ICANS, Grade Unspecified
- CAR T-Cell-Related Encephalopathy Syndrome
- There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
-
Freiburg, Baden Württemberg, GermanyFreiburg University Medical Center
Apr 12, 2023
Human Leukocyte Antigen Typing and Tumor Antigen Expression
Recruiting
- Refractory Cancer
- +3 more
-
Chicago, Illinois
- +3 more
Feb 14, 2022
Dysferlinopathy, Miyoshi Myopathy, LGMDR2 Trial in Moscow
Enrolling by invitation
- Dysferlinopathy
- +3 more
-
Moscow, Russian FederationHuman Stem Cells Institute
Jul 25, 2022
Resected Pancreatic Adenocarcinoma
Completed
- Pancreatic Cancer Resectable
- Multigene panel for next-generation sequencing
-
Shanghai, Shanghai, ChinaRuijin Hospital
Jul 31, 2022
A Study of the Effectiveness of Moderna COVID-19 Vaccine
Recruiting
- SARS-CoV-2
- COVID-19
- mRNA-1273
-
Pasadena, CaliforniaKaiser Permanente Southern California
Jul 5, 2023
COVID-19 Novel Molecular Point of Care Diagnostics Evaluation
Completed
- COVID-19 Respiratory Infection
-
Geneva, Switzerland
- +2 more
Sep 25, 2023
Beta Thalassaemia Trial in Milan (Safety and Efficacy assessments)
Active, not recruiting
- Beta Thalassaemia
- Safety and Efficacy assessments
-
Milan, ItalyOspedale San Raffaele - Telethon Institute for Gene Therapy (OSR
Nov 22, 2022
Shear-wave Elastography in Breast Cancer
Not yet recruiting
- Breast Cancer
- elastography
- (no location specified)
Nov 3, 2023
Prostate Cancer Trial in Zürich (MDPK67b)
Recruiting
- Prostate Cancer
-
Zürich, SwitzerlandKlinik für Urologie, UniversitätSpital Zürich (USZ)
Oct 11, 2022
Triple-negative Breast Cancer Trial in Shanghai (A1: SHR-A1811, A2: SHR-A1811 with Camrelizumab, B1: TROP2 ADC)
Not yet recruiting
- Triple-negative Breast Cancer
- A1: SHR-A1811
- +11 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 19, 2023
COVID-19 Respiratory Infection Trial in Chelsea (SARS CoV-2 antigen tests)
Recruiting
- COVID-19 Respiratory Infection
- SARS CoV-2 antigen tests
-
Chelsea, MassachusettsChelsea Housing Authority
Jun 1, 2023
SARS-CoV-2 Antigen RDT Evaluation COVID-19 Antigen Rapid
Completed
- Corona Virus Infection
- The Abbott Panbio™ COVID-19 Ag Rapid Test
-
Gaborone, Gabonone, BotswanaBotswana Harvard AIDS Institute Partnership
Jun 19, 2023